Michael Dovey

Michael Dovey is an accomplished professional in the biopharmaceutical industry, currently serving as the Executive Director of Corporate Development at Apellis Pharmaceuticals since August 2019. Dovey has a robust background in nephrology program leadership and global business intelligence. Prior experience includes a significant role at Biogen from October 2012 to August 2019, where Dovey led Alzheimer's initiatives and contributed to R&D portfolio analytics and US decision support. Earlier experience as a consultant at L.E.K. Consulting involved providing strategic insights to mid-large biopharma, venture-stage startups, and private equity clients. Michael Dovey holds a PhD in Genetics from Harvard University and a BA in Biochemistry from Occidental College.